0 0 0
This online shop is using cookies to give you the best shopping experience. Thereby for example the session information or language setting are stored on your computer. Without cookies the range of the online shop's functionality is limited. If you don't agree, please click here.

Gilbert, Weiner, NKF Primer on Kidney Diseases

National Kidney Foundation

ISBN: 978-0-443-26193-0

Edition: 9th Ed.

Publication date: December 2026

Cover: Softcover + Digital: online access

Pages: 688 p.

Illustrations: 120 ill.

Publisher: Elsevier, Radarweg 29, NL 1043 NX Amsterdam, productsafety@elsevier.com

Not yet published, price to be announced. Your order will be recorded. Plus postage outside Germany.

Description

Covering every relevant topic in this fast-changing field, National Kidney Foundation's Primer on Kidney Diseases, 9th Edition, remains your #1 source of practical, authoritative information in nephrology. Using a clear, concise, and accessible format, this bestselling guide provides well organized, highly readable guidance for residency, fellowship, clinical practice, and board review. The fully revised Primer brings you up to date with all that’s new in the field, including ongoing clinical research and changing treatment protocols. Offering authoritative coverage of the full breadth of nephrology from world leaders in their field, this joint publication of Elsevier and the National Kidney Foundation is both an essential learning tool for trainees and an easy-to-use, reliable reference for practicing clinicians at the point of care.

  • Provides clear, comprehensive coverage of every aspect of nephrology— from foundational science and clinical evaluation to glomerular disease, systemic disease, AKI, CKD, dialysis, transplantation, pediatrics, pregnancy, and hypertension
  • Presents complex material in a clear, easy-to-understand manner that is both accessible to residents and fellows and comprehensive enough for practicing nephrologists
  • Contains a new chapter on Critical Care Nephrology that equips clinicians with a practical, phenotype-driven approach to diagnosing and managing AKI in the ICU
  • Covers major advances in treating glomerular diseases, including updated KDIGO guidelines and the rapid growth of precision therapies such as C3 inhibitors, BTK inhibitors, and podocyte-targeted agents
  • Includes new and expanded coverage of SGLT2 inhibitors, nonsteroidal MRAs, and GLP-1 receptor agonists for kidney and cardiovascular protection in diabetic and non-diabetic CKD
  • An eBook version is included with purchase. The eBook allows you to access all of the text, figures, and references, with the ability to search, make notes and highlights, and have content read aloud. Additional digital ancillary content may publish after the publication date